Financials
- Fiscal year
- 2024
- Total assets
- €305,613
- Loss
- -€4,573
- Solvency
- -14.7%
Total assets▼ 6.8%
Net result
20182024
IMMOBOX
InactiveOverview
Activity
Activity not known
Size
€305,613total assets 2024
- Equity
- -€44,918
- Loss
- -€4,573
Financial health
Inactive: no score
Structure
- Parent
- Multipharma · 100%
Accounts 65 d overdue0 of 7 deeds read
Signals- Negative equityLatest accounts filed on timeShow the evidence
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year -€44,918
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-06-2025, 38 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
38 d early
2023
111 d early
2022
3 d early
2021
16 d early
2020
32 d early
2019
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 6 accounts on average 38 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · full…
- Annual accounts filedfiscal year 2023 · abbreviated…
- Annual accounts filedfiscal year 2022 · abbreviated…
Key points
By topic
Board & ownership
- Parent
- Multipharma · 100%
Network & group
- Group
- MULTIPHARMA GROUP
Timeline
- Events
- 10
- Since
- 2018
- 23-06-2025Annual accounts filed
- 11-04-2024Annual accounts filed
- 28-07-2023Annual accounts filed
Company details
- Year ends
- 31-12
- Peppol
- Not found in the Peppol directory
Go further with this company
Who ran this company, and where was it based, on a date before the end?Company as of a date Which other companies belong to the same group?MULTIPHARMA GROUP · 10 companies
Investigating this company? Keep it with today's facts in a case file.